Authors: VANHOECKE C FU D DEGRAVE D VOET P LEBACQ E

Citation: C. Vanhoecke et al., CLINICAL AND IMMUNOLOGICAL ASSESSMENT OF A CANDIDATE LYME-DISEASE VACCINE IN HEALTHY-ADULTS - ANTIBODY PERSISTENCE AND EFFECT OF A BOOSTER DOSE AT MONTH 12, Vaccine, 16(17), 1998, pp. 1688-1692

Authors: LEROUXROELS G DESOMBERE I DETOLLENAERE G PETIT MA DESMONS P HAUSER P DELEM A DEGRAVE D SAFARY A

Citation: G. Lerouxroels et al., HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .1. SAFETY AND IMMUNOGENICITY IN YOUNG, HEALTHY-ADULTS, Vaccine, 15(16), 1997, pp. 1724-1731

Authors: LEROUXROELS G DESOMBERE I COBBAUT L PETIT MA DESMONS P HAUSER P DELEM A DEGRAVE D SAFARY A

Citation: G. Lerouxroels et al., HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .2. IMMUNOGENICITY IN POOR RESPONDERS TO HEPATITIS-B VACCINES, Vaccine, 15(16), 1997, pp. 1732-1736

Authors: VANHOECKE C COMBERBACH M DEGRAVE D DESMONS P FU D HAUSER P LEBACQ E LOBET Y VOET P

Citation: C. Vanhoecke et al., EVALUATION OF THE SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF 3 RECOMBINANT OUTER SURFACE PROTEIN (OSPA) LYME VACCINES IN HEALTHY-ADULTS, Vaccine, 14(17-18), 1996, pp. 1620-1626

Authors: KANRA G CEYHAN M ECEVIT Z BOGAERTS H DEGRAVE D HAUSER P DESMONS P

Citation: G. Kanra et al., PRIMARY VACCINATION OF INFANTS WITH A COMBINED DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-HEPATITIS-B VACCINE, The Pediatric infectious disease journal, 14(11), 1995, pp. 998-1000

Authors: HE QS VILJANEN MK OLANDER RM BOGAERTS H DEGRAVE D RUUSKANEN O MERTSOLA J

Citation: Qs. He et al., ANTIBODIES TO FILAMENTOUS HEMAGGLUTININ OF BORDETELLA-PERTUSSIS AND PROTECTION AGAINST WHOOPING-COUGH IN SCHOOLCHILDREN, The Journal of infectious diseases, 170(3), 1994, pp. 705-708